Polynovo Limited (PNV) - Research

$0.955
Prices as at 16:40, 26 Apr 2019

PNV Current Share Price+

Current Price $0.955
Open $0.955
High $0.970
Low $0.945
Last Close $0.955
Volume 1431336
Price Movement - ( No change )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

PNV General Information

Polynovo Limited
PNV
http://www.polynovo.com.au
Biotechnology
631
661

PNV Company Overview

Business Description

Polynovo Limited (PNV, formerly Calzada Limited) is an Australian based medical device company that designs, develops and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Their development program covers Breast Sling, Hernia, and Orthopedic applications.

PNV Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2018 A -5.97 -1.00 0.00% 0.00 0.00 0.00% 0.0%
2017 A -5.01 -0.90 0.00% 0.00 0.00 0.00% 0.0%
2016 A -3.25 -0.60 0.00% 0.00 0.00 0.00% 0.0%

PNV Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2016 A 2017 A 2018 A 2016 A 2017 A 2018 A 2016 A 2017 A 2018 A
CSL (CSL) $86,257M 0.3775 0.1257 0.1290 36.2679 32.2170 28.5348 1.62% 1.42% 1.63%
Clinuvel Pharmaceuticals (CUV) $1,089M 0.8671 0.0000 0.0000 83.3333 0.0000 0.0000 0.09% 0.00% 0.00%
Mesoblast (MSB) $780M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Monash IVF Group (MVF) $249M -0.2744 0.0000 0.0000 11.6318 0.0000 0.0000 5.69% 0.00% 0.00%
Polynovo (PNV) $612M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

PNV Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 22.10 0.00
Market 0.71 14.90 1.20 1.08
Sector 1.02 24.40 3.31 2.83

PNV Directors

Name Position Start Date
Mr Bruce Rathie Non-Executive Director 18 Feb 2010
Mr Philip (Phil) John Powell Non-Executive Director 13 May 2014
Mr Robert (Max) Maxwell Johnston Non-Executive Director 13 May 2014
Dr David McQuillan Non-Executive Director 6 Aug 2012
Mr Leon Hoare Non-Executive Director 27 Jan 2016
Mr David Williams Non-Executive Director, Non-Executive Chairman 28 Feb 2014

PNV Management

Name Position
Paul Brennan Chief Executive Officer
Jan-Marcel Gielen Chief Financial Officer,Company Secretary

PNV Substantial Shareholders

Holding Name
41,805,387 (43.99%) HSBC Custody Nominees (Australia) Limited
38,523,183 (40.54%) Citicorp Nominees Pty Limited

PNV Calendar of Events

Date Event
20 February 2020 Report (Interim)
11 October 2019 Report (Prelim)
11 October 2019 Report (Annual)
15 August 2019 Report (Annual)
15 August 2019 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.